NEWS
![](https://oslocancercluster.no/wp-content/uploads/2023/08/IMG_20190813_164213-260x185.jpg)
Arendalsuka 2023
Møt oss i Arendal! Vi snakker om kreftinnovasjon med politikerne.
![](https://oslocancercluster.no/wp-content/uploads/2023/08/IMG_20230524_152522_web-1-260x185.jpg)
AI for more precise radiation therapy
Learn how artificial intelligence is changing radiation therapy.
![](https://oslocancercluster.no/wp-content/uploads/2023/06/Pascal-van-Peborgh-Gilead_web-260x185.png)
Gilead joins Oslo Cancer Cluster
Gilead is a biopharmaceutical company advancing innovative medicines
![](https://oslocancercluster.no/wp-content/uploads/2023/06/IMG_20230620_111057_web-260x185.jpg)
Polygenic risk scores: a European cancer priority
Polygenic risk scores can improve prevention and early detection of cancer.
![](https://oslocancercluster.no/wp-content/uploads/2023/06/IMG_1666-1_web2-260x185.jpg)
New targeted therapy against osteosarcoma
Research group in Oslo Cancer Cluster Incubator develops new cancer treatment
![](https://oslocancercluster.no/wp-content/uploads/2023/06/PXL_20230605_152733237.MP52559_web-260x185.jpg)
Oncology innovators presented in Boston
Three Nordic start-ups pitched at the International Cancer Cluster…
![](https://oslocancercluster.no/wp-content/uploads/2023/06/IMG_20230606_094934-web-260x185.jpg)
Cancer start-ups met investors
Investors wanted to learn about Norwegian cancer companies.
![Two men and a woman looking into the camera](https://oslocancercluster.no/wp-content/uploads/2023/06/lederne_HC_3_web_occ-260x185.png)
Forenkler testing av helseteknologi sammen
NorTrials Medisinsk utstyr har inngått en samarbeidsavtale med HealthCatalyst AS.
![](https://oslocancercluster.no/wp-content/uploads/2023/06/KetilWiderberg_IngridStenstadvoldRoss_OyvindKongstunArnesen_new-260x185.jpg)
Oslo Cancer Cluster strengthens the board
Patient and industry perspectives are key as new board members join Oslo Cancer Cluster.